WW International reported Q1 2024 revenues of $206.5 million. The company's end-of-period subscribers remained steady at 4.0 million, including 91,000 clinical subscribers. The company experienced an operating loss of $269.3 million, primarily due to non-cash intangible impairment charges, but adjusted operating loss was $5.6 million excluding these charges and restructuring costs.
End of period subscribers totaled 4.0 million, which included 91,000 clinical subscribers.
Revenues reached $206.5 million.
Operating loss was $269.3 million, impacted by $258.0 million in non-cash intangible impairment charges.
The company is maintaining its revenue guidance for 2024, anticipating a return to year-over-year growth in subscription revenues.
The company provided an update to its full year fiscal 2024 guidance, maintaining its revenue outlook and adjusting operating income expectations.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance